BackChina National Medicines Ltd. Overview

China National Medicines Ltd. Inventory

China National Medicines Ltd.'s inventory is $5.5B.

Get informed when a big investor buys or sells

+ Follow
Inventory
$5.47B
↑ 3.03% YoYΔ $160.55M vs prior year quarter

Peer trimmed avg / median

Loading

China National Medicines Ltd. Inventory History

Loading

China National Medicines Ltd. vs. peers: Inventory Comparison

Loading

China National Medicines Ltd. Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

China National Medicines Ltd. (600511.SS) FAQ

As of the most recent data (June 2026), 600511.SS shows a inventory of $5.5B. That compares with $5.3B in the prior-year period — up 3.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 600511.SS's inventory is now $5.5B (was $5.3B) — a 3.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether China National Medicines Ltd. is outperforming or lagging.

Tracking 600511.SS's inventory over time shows whether China National Medicines Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $5.5B That compares with $5.3B in the prior-year period — up 3.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has China National Medicines Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $5.5B) with ownership activity and broader fundamentals.